See below: Interferon-beta1a, when used in the treatment of relapsing-remitting MS has been show to reduce the annualized relapse frequency, reduce disease progression and improve quality of life.
Answered 1/13/2016
5.8k views
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question